Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　― The Prospective KYU-RABLE Study ―-Reference-Cited by-同舟云学术

Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　― The Prospective KYU-RABLE Study ―

Published:2019-09-25 Issue:10 Volume:83 Page:2017-2024
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Takahashi Naohiko¹,Mukai Yasushi²,Kimura Tetsuya³,Yamaguchi Keita³,Matsumoto Takuyuki⁴,Origasa Hideki⁵,Okumura Ken⁶,

Affiliation:

1. Department of Cardiology and Clinical Examination, Oita University Faculty of Medicine

2. Cardiology Division, Japanese Red Cross Fukuoka Hospital

3. Medical Science Department, Daiichi Sankyo Co., Ltd.

4. Safety and Risk Management Department, Daiichi Sankyo Co., Ltd.

5. Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences

6. Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/10/83_CJ-19-0535/_pdf

Reference17 articles.

1. 1. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32–38.

2. 2. Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: Results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation 2014; 129: 2638–2644.

3. 3. Hohnloser SH, Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: A meta-analysis of the literature. Europace 2013; 15: 1407–1411.

4. 4. Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J 2015; 36: F1805–F1811.

5. 5. Okumura K, Aonuma K, Kumagai K, Hirao K, Inoue K, Kimura M, et al. Efficacy and safety of rivaroxaban and warfarin in the perioperative period of catheter ablation for atrial fibrillation: Outcome analysis from a prospective multicenter registry study in Japan. Circ J 2016; 80: 2295–2301.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Edoxaban eliminates hypercoagulability evoked by transient temperature changes in human whole blood;Journal of Arrhythmia;2023-11-06

2. Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques;Journal of Clinical Medicine;2023-10-15

3. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Circulation Journal;2022-10-25

4. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Journal of Arrhythmia;2022-10-25

5. D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban;Journal of Cardiology;2022-06